Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Dec;102(3):476–480. doi: 10.1111/j.1365-2249.1995.tb03840.x

Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.

A Mabondzo 1, P Rouvier 1, H Raoul 1, R Le Naour 1, C Courpotin 1, F Hervé 1, F Parnet-Mathieu 1, G Lasfargues 1, D Dormont 1
PMCID: PMC1553385  PMID: 8536360

Abstract

Based on what is known about the biology of HIV-1 vertical transmission, the HIV burden of the mother, maternal immune factors and the integrity of the placental barrier are likely to play major roles. We therefore sought to determine whether the presence of antibodies in sera from 47 HIV-1-infected mothers, including 30 non-transmitting and 17 transmitting mothers, affected the risk of HIV-1 transmission to infants. Our findings showed no significant correlation between the capacity of antibodies to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and their capacity to induce protection of the child from HIV-1 infection (P = 0.14). Furthermore, no correlation was found between the capacity of maternal antibodies to neutralize in vitro lymphocyte or macrophage heterologous viral infection and the occurrence of in vivo HIV-1 infection in the infant. Sera recovered from five of 12 transmitting mothers and from five of 11 non-transmitting mothers were compared in their capacity to neutralize the viruses drawn from the same individuals. Four out of five maternal isolates from transmitting mothers and all maternal isolates from non-transmitting mothers were sensitive to enhancement of infection mediated by the maternal serum.

Full text

PDF
476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boussin F., Dormont D., Merrouche Y., Fleury H., Dubeaux D., Bequet D., Goasguen J., Brunet P. Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) years. Lancet. 1987 Sep 5;2(8558):571–572. doi: 10.1016/s0140-6736(87)92957-6. [DOI] [PubMed] [Google Scholar]
  2. Broliden K., Sievers E., Tovo P. A., Moschese V., Scarlatti G., Broliden P. A., Fundaro C., Rossi P. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children. Clin Exp Immunol. 1993 Jul;93(1):56–64. doi: 10.1111/j.1365-2249.1993.tb06497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Courgnaud V., Lauré F., Brossard A., Bignozzi C., Goudeau A., Barin F., Bréchot C. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses. 1991 Mar;7(3):337–341. doi: 10.1089/aid.1991.7.337. [DOI] [PubMed] [Google Scholar]
  4. Devash Y., Calvelli T. A., Wood D. G., Reagan K. J., Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci U S A. 1990 May;87(9):3445–3449. doi: 10.1073/pnas.87.9.3445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Douglas S. D. Immunological and virological clues for mother-to-child transmission of HIV-1 and HIV-2. JAMA. 1994 Aug 10;272(6):487–488. [PubMed] [Google Scholar]
  6. Folks T. M., Powell D., Lightfoote M., Koenig S., Fauci A. S., Benn S., Rabson A., Daugherty D., Gendelman H. E., Hoggan M. D. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986 Jul 1;164(1):280–290. doi: 10.1084/jem.164.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gartner S., Markovits P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986 Jul 11;233(4760):215–219. doi: 10.1126/science.3014648. [DOI] [PubMed] [Google Scholar]
  8. Homsy J., Meyer M., Levy J. A. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol. 1990 Apr;64(4):1437–1440. doi: 10.1128/jvi.64.4.1437-1440.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kesson A. M., Fear W. R., Williams L., Chang J., King N. J., Cunningham A. L. HIV infection of placental macrophages: their potential role in vertical transmission. J Leukoc Biol. 1994 Sep;56(3):241–246. doi: 10.1002/jlb.56.3.241. [DOI] [PubMed] [Google Scholar]
  10. Lindgren S., Anzén B., Bohlin A. B., Lidman K. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. AIDS. 1991 Sep;5(9):1111–1116. [PubMed] [Google Scholar]
  11. Ljunggren K., Fenyö E. M., Biberfeld G., Jondal M. Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. J Immunol Methods. 1987 Nov 23;104(1-2):7–14. doi: 10.1016/0022-1759(87)90481-9. [DOI] [PubMed] [Google Scholar]
  12. Ljunggren K., Moschese V., Broliden P. A., Giaquinto C., Quinti I., Fenyö E. M., Wahren B., Rossi P., Jondal M. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis. 1990 Feb;161(2):198–202. doi: 10.1093/infdis/161.2.198. [DOI] [PubMed] [Google Scholar]
  13. Mabondzo A., Aussage P., Bartholeyns J., Le Naour R., Raoul H., Romet-Lemonne J. L., Dormont D. Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection. J Infect Dis. 1992 Jul;166(1):93–99. doi: 10.1093/infdis/166.1.93. [DOI] [PubMed] [Google Scholar]
  14. Mabondzo A., Boussin F., Raoul H., Le Naour R., Gras G., Vaslin B., Bartholeyns J., Romet-Lemonne J. L., Dormont D. Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody. J Gen Virol. 1994 Jun;75(Pt 6):1451–1456. doi: 10.1099/0022-1317-75-6-1451. [DOI] [PubMed] [Google Scholar]
  15. Montefiori D. C., Zhou I. Y., Barnes B., Lake D., Hersh E. M., Masuho Y., Lefkowitz L. B., Jr Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology. 1991 Jun;182(2):635–643. doi: 10.1016/0042-6822(91)90604-a. [DOI] [PubMed] [Google Scholar]
  16. Parekh B. S., Shaffer N., Pau C. P., Abrams E., Thomas P., Pollack H., Bamji M., Kaul A., Schochetman G., Rogers M. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS. 1991 Oct;5(10):1179–1184. doi: 10.1097/00002030-199110000-00004. [DOI] [PubMed] [Google Scholar]
  17. Robertson C. A., Mok J. Y., Froebel K. S., Simmonds P., Burns S. M., Marsden H. S., Graham S. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis. 1992 Oct;166(4):704–709. doi: 10.1093/infdis/166.4.704. [DOI] [PubMed] [Google Scholar]
  18. Rook A. H., Lane H. C., Folks T., McCoy S., Alter H., Fauci A. S. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol. 1987 Feb 15;138(4):1064–1067. [PubMed] [Google Scholar]
  19. Roques P., Humbert M., Dormont D. Neonatal diagnosis of HIV infection. Lancet. 1991 Sep 7;338(8767):631–631. doi: 10.1016/0140-6736(91)90638-6. [DOI] [PubMed] [Google Scholar]
  20. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., Fenyö E. M. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis. 1993 Jul;168(1):207–210. doi: 10.1093/infdis/168.1.207. [DOI] [PubMed] [Google Scholar]
  21. Schwartz D. A., Nahmias A. J. Human immunodeficiency virus and the placenta. Current concepts of vertical transmission in relation to other viral agents. Ann Clin Lab Sci. 1991 Jul-Aug;21(4):264–274. [PubMed] [Google Scholar]
  22. Weiss R. A., Clapham P. R., Weber J. N., Dalgleish A. G., Lasky L. A., Berman P. W. Variable and conserved neutralization antigens of human immunodeficiency virus. Nature. 1986 Dec 11;324(6097):572–575. doi: 10.1038/324572a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES